208 related articles for article (PubMed ID: 9388858)
1. [The expression of Rb, p16 and cyclin D1 in 41 esophageal cancers].
Zheng J; Zhou C; Xiao F
Zhonghua Bing Li Xue Za Zhi; 1996 Dec; 25(6):336-9. PubMed ID: 9388858
[TBL] [Abstract][Full Text] [Related]
2. Early deregulation of the the p16ink4a-cyclin D1/cyclin-dependent kinase 4-retinoblastoma pathway in cell proliferation-driven esophageal tumorigenesis in zinc-deficient rats.
Fong LY; Nguyen VT; Farber JL; Huebner K; Magee PN
Cancer Res; 2000 Aug; 60(16):4589-95. PubMed ID: 10969811
[TBL] [Abstract][Full Text] [Related]
3. Alterations of the cyclin D1/p16-pRB pathway in mantle cell lymphoma.
Dreyling MH; Bullinger L; Ott G; Stilgenbauer S; Müller-Hermelink HK; Bentz M; Hiddemann W; Döhner H
Cancer Res; 1997 Oct; 57(20):4608-14. PubMed ID: 9377576
[TBL] [Abstract][Full Text] [Related]
4. Cyclin D1 amplification is independent of p16 inactivation in head and neck squamous cell carcinoma.
Okami K; Reed AL; Cairns P; Koch WM; Westra WH; Wehage S; Jen J; Sidransky D
Oncogene; 1999 Jun; 18(23):3541-5. PubMed ID: 10376532
[TBL] [Abstract][Full Text] [Related]
5. Expression of cyclin D1, CDK4 and p27KIP1 is associated with the p16MTS1 gene status in human esophageal carcinoma cell lines.
Kitahara K; Yasui W; Yokozaki H; Semba S; Hamamoto T; Hisatsugu T; Tahara E
J Exp Ther Oncol; 1996 Jan; 1(1):7-12. PubMed ID: 9414383
[TBL] [Abstract][Full Text] [Related]
6. Role of p16/MTS1, cyclin D1 and RB in primary oral cancer and oral cancer cell lines.
Sartor M; Steingrimsdottir H; Elamin F; Gäken J; Warnakulasuriya S; Partridge M; Thakker N; Johnson NW; Tavassoli M
Br J Cancer; 1999 Apr; 80(1-2):79-86. PubMed ID: 10389982
[TBL] [Abstract][Full Text] [Related]
7. Expression of p16, Rb, and cyclin D1 gene products in oral and laryngeal squamous carcinoma: biological and clinical implications.
El-Naggar AK; Lai S; Clayman GL; Zhou JH; Tucker SA; Myers J; Luna MA; Benedict WF
Hum Pathol; 1999 Sep; 30(9):1013-8. PubMed ID: 10492034
[TBL] [Abstract][Full Text] [Related]
8. Disruption of the RB pathway and cell-proliferative activity in non-small-cell lung cancers.
Tanaka H; Fujii Y; Hirabayashi H; Miyoshi S; Sakaguchi M; Yoon HE; Matsuda H
Int J Cancer; 1998 Apr; 79(2):111-5. PubMed ID: 9583722
[TBL] [Abstract][Full Text] [Related]
9. Further evidence that altered p16/CDKN2 gene expression is associated with lymph node metastasis in squamous cell carcinoma of the esophagus.
Takeuchi H; Ozawa S; Ando N; Kitagawa Y; Mukai M; Ueda M; Kitajima M
Oncol Rep; 2001; 8(3):627-32. PubMed ID: 11295092
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of the P27KIP1 protein in human esophageal cancer cell lines that over-express cyclin D1.
Doki Y; Imoto M; Han EK; Sgambato A; Weinstein IB
Carcinogenesis; 1997 Jun; 18(6):1139-48. PubMed ID: 9214595
[TBL] [Abstract][Full Text] [Related]
11. Altered expression of cell cycle regulators Cyclin D1, p14, p16, CDK4 and Rb in nodular melanomas.
Bachmann IM; Straume O; Akslen LA
Int J Oncol; 2004 Dec; 25(6):1559-65. PubMed ID: 15547691
[TBL] [Abstract][Full Text] [Related]
12. Infrequent alternations of RB pathway (Rb-p16INK4A-cyclinD1) in adenoid cystic carcinoma of salivary glands.
Shintani S; Mihara M; Nakahara Y; Kiyota A; Yoshihama Y; Ueyama Y; Matsumura T
Anticancer Res; 2000; 20(3B):2169-75. PubMed ID: 10928172
[TBL] [Abstract][Full Text] [Related]
13. Effect of cyclin D1 and associated proteins on proliferation of esophageal squamous cell carcinoma.
Shamma A; Doki Y; Shiozaki H; Tsujinaka T; Inoue M; Yano M; Kimura Y; Yamamoto M; Monden M
Int J Oncol; 1998 Sep; 13(3):455-60. PubMed ID: 9683778
[TBL] [Abstract][Full Text] [Related]
14. Reciprocal Rb inactivation and p16INK4 expression in primary lung cancers and cell lines.
Shapiro GI; Edwards CD; Kobzik L; Godleski J; Richards W; Sugarbaker DJ; Rollins BJ
Cancer Res; 1995 Feb; 55(3):505-9. PubMed ID: 7834618
[TBL] [Abstract][Full Text] [Related]
15. Multigene analysis of Rb pathway and apoptosis control in esophageal squamous cell carcinoma identifies patients with good prognosis.
Güner D; Sturm I; Hemmati P; Hermann S; Hauptmann S; Wurm R; Budach V; Dörken B; Lorenz M; Daniel PT
Int J Cancer; 2003 Feb; 103(4):445-54. PubMed ID: 12478659
[TBL] [Abstract][Full Text] [Related]
16. [The expression of P16, Rb and cyclin D1 and biological behavior of laryngeal cancer].
Dai S; Huang W; Gan X
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1997 Oct; 32(5):299-301. PubMed ID: 10743098
[TBL] [Abstract][Full Text] [Related]
17. Ovarian cancer cells that coexpress endogenous Rb and p16 are insensitive to overexpression of functional p16 protein.
Todd MC; Sclafani RA; Langan TA
Oncogene; 2000 Jan; 19(2):258-64. PubMed ID: 10645004
[TBL] [Abstract][Full Text] [Related]
18. [The expression of p53, p16, cyclin D1 in esophageal squamous cell carcinoma and esophageal dysplasia].
Kim SG; Hong SJ; Kwon KW; Jung SW; Kim WY; Jung IS; Ko BM; Ryu CB; Kim YS; Moon JH; Kim JO; Cho JY; Lee JS; Lee MS; Shim CS; Kim BS
Korean J Gastroenterol; 2006 Oct; 48(4):269-76. PubMed ID: 17060721
[TBL] [Abstract][Full Text] [Related]
19. Alterations of Rb pathway (Rb-p16INK4-cyclin D1) in preinvasive bronchial lesions.
Brambilla E; Gazzeri S; Moro D; Lantuejoul S; Veyrenc S; Brambilla C
Clin Cancer Res; 1999 Feb; 5(2):243-50. PubMed ID: 10037171
[TBL] [Abstract][Full Text] [Related]
20. Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16.
Lukas J; Parry D; Aagaard L; Mann DJ; Bartkova J; Strauss M; Peters G; Bartek J
Nature; 1995 Jun; 375(6531):503-6. PubMed ID: 7777060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
